Skip to main navigation Skip to search Skip to main content

A 6-month, Multi-center, Radnomized, Open-Label, 2 Arm, Parallel Group Study Comparing the Efficacy and Safety of a New formulation of Insulin Glargine and Lantus

Project: Research

Project Details

StatusFinished
Effective start/end date04/14/16 → 09/7/22

Funding

  • Sanofi US Services Incorporated: $109,426.00